Harper og Vedel IS

What Harper og Vedel IS does

Harper & Vedel is a private Danish engineering consulting firm founded in 2011 by Peter Harper and Jesper Vedel, providing independent advisory services to biotechnology, pharmaceutical, nutraceutical, and fine chemicals companies. The firm is organized as A/S Harper & Vedel and is headquartered at Bernstorff Slot in Gentofte, Denmark. It serves end-user clients across the full industry range from API production through drug products to medical devices, and is part of XPartners Group, a Nordic engineering and design consultancy bringing together more than 2,000 specialists across infrastructure, buildings, energy, life science, and environment — the parent being majority employee-owned.

The firm operates as a boutique professional services practice structured around four service lines: Concept/Strategy Studies (early-stage strategic assessment of greenfield, revamp, and build/buy decisions, with explicit independence from the contracting and execution side of capital expenditure), Critical Staff Services (short lead-time staff augmentation ranging from junior production chemists to interim project directors and SME profiles for core customers), Engineering Process Flow Management (client-side execution activity planning and oversight in dealing with large EPCm contractors, with a stated production-process perspective rather than standalone project management), and Decision Science Services (production modelling and capacity simulation using industry standard methods applied to client plant data to support what-if analysis of capacity, portfolio, staffing, and equipment changes). The stated underlying technology is industry-standard modelling and simulation methodology rather than proprietary platforms, AI systems, or software products; no APIs, SDKs, patents, or AI capabilities are disclosed.

Harper & Vedel generates revenue through professional services fees on direct consulting engagements, with an enterprise field-sales GTM motion aimed at biotech, pharmaceutical, nutraceutical, and fine chemicals end-users. Pricing is not publicly disclosed; the firm does not announce funding rounds, financial results, or M&A activity. The team comprises approximately 25 permanent staff plus 10+ senior freelancers, with multiple partners and senior principal consultants in addition to the founding senior advisors. Marketing and demand generation run through the company website and a LinkedIn presence, with team-level direct contacts published for inbound enterprise engagement.

Name

Harper og Vedel IS

Legal name

A/S Harper & Vedel

Website

https://harper-vedel.com

Company type

Private

Founded year

2011

Operating status

Operating

Headcount range

11–50 employees

Short description

Harper & Vedel is a Danish engineering consulting firm founded in 2011 that delivers independent advisory services to biotechnology, pharmaceutical, nutraceutical, and fine chemicals companies spanning API production to medical devices. Its work covers strategy studies, staff augmentation, project flow management, and capacity simulation.

Ownership category

akta.pro rank

Product category

Engineering Consulting Services

NAICS

Engineering Services (54133), Management, Scientific, and Technical Consulting Services (5416), Management Consulting Services (54161)

SIC

Services-Engineering Services (8711), Services-Management Consulting Services (8742)

akta.pro primary industry

Industrial & Process Engineering Consulting (BPAHAIAF)

Keywords

• Engineering consulting services
• Pharmaceutical advisory
• Biotech consulting
• Production modelling
• Capacity simulation

Headquarters

HQ city

Søborg

HQ country

Denmark

HQ region

Europe

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Marketing or Sales

Revenue model

1. Engineering Consulting Services: Extended engineering consulting services offered to end-user clients across the full industry range from API Production via Drug Products to Medical Devices. Services include Engineering Assisted R&D, Implementation phases, Operation and Continuous Improvement, Concept/Strategy Studies, Critical Staff Services, Engineering Process Flow Management, and Decision Science Services.
2. Staff Augmentation: Staff augmentation services with short lead-time for core customers. Staff levels range from junior production chemists to interim project directors as well as SME profiles.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels2 records

Core offering

Harper & Vedel delivers Extended Engineering Consulting Services to end-user clients in biotech, pharmaceutical, nutraceutical, and fine chemicals industries. The offering spans Engineering Assisted R&D, Implementation phases, Operation and Continuous Improvement, Concept/Strategy Studies, Critical Staff Services, Engineering Process Flow Management, and Decision Science Services, covering the full industry range from API Production via Drug Products to Medical Devices.

Product overview

Harper & Vedel offers Extended Engineering Consulting Services as a portfolio of four interconnected service lines targeting biotech, pharmaceutical, nutraceutical, and fine chemicals companies. The services span from early-stage Concept/Strategy Studies through Critical Staff Services for project staffing needs, Engineering Process Flow Management for execution support, and Decision Science Services for data-driven capacity and production modelling. The offering represents a unified advisory approach without ties to the contracting and execution side of CapEx, providing independent guidance across the full industry range from API Production via Drug Products to Medical Devices.

Differentiator

Problem solved

Functional benefit

Products and services

• Concept/Strategy Studies Strategic assessment and business advisory services for early-stage decisions including green field facilities, production revamps, and build/buy studies, providing unbiased advice on cost, capacity, equipment vendor selection, execution strategy, and EPCm contractor choice for biotech, pharmaceutical, nutraceutical, and fine chemicals clients.
• Critical Staff Services Staff augmentation services providing short-lead-time placement of junior production chemists, interim project directors, and SME profiles for project-based staffing needs of core customers in biotech, pharmaceutical, nutraceutical, and fine chemicals.
• Engineering Process Flow Management Project flow management services with a production process perspective, assisting clients in executing Client Side Execution Activity Plans when engaging large EPCm contractors, maximising the impact of project activities and fostering positive project experiences.
• Decision Science Services Production modelling and capacity simulation services that apply industry-standard methods to client plant data and operations behaviour, providing a decision platform for cheap and fast what-if analysis of capacity changes, product portfolio shifts, staffing profiles, and equipment upgrades for biotech, pharmaceutical, nutraceutical, and fine chemicals clients.

Segments4 records

Ideal customer profiles4 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Partnerships

One partnership is on record.

• XPartners GroupcoreStrategic or Co-development PartnerHarper & Vedel is part of XPartners Group, a Nordic consultant within engineering and design. The group brings together more than 2,000 specialists who advise clients in infrastructure, buildings, energy, life science and the environment. The group is majority-owned by the employees. This partnership provides scale and resources while Harper & Vedel maintains its specialized focus on biotech, pharmaceutical, nutraceutical, and fine chemicals advisory services.

Scale indicators1 record

Recent moves6 records

Expansion highlights4 records

Emerging players

• ProPharma Group: Life sciences consulting firm providing pharma and biotech clients with compliance, regulatory and operational consulting; has overlapping biotech/pharma client base but focuses more on regulatory and quality rather than engineering advisory and process flow management.

Direct peers

• IPS (Integrated Project Services): Global leader in pharma engineering, architecture, construction and compliance consulting serving biotech, pharma and medical device manufacturers; competes directly for the same C&Q, project execution and early-stage advisory work Harper & Vedel performs, although at significantly larger global scale.
• PSC Biotech: Life sciences consulting firm providing commissioning, qualification, validation, engineering and staffing services to pharma and biotech clients; overlaps with Harper & Vedel's Critical Staff Services and CQV-adjacent offerings, particularly in regulated European markets.
• NNE: Danish pharma-focused engineering consultancy originally serving Novo Nordisk; offers concept studies, basic/detail design and validation services to biotech and pharma clients across the full value chain - directly overlapping with Harper & Vedel's Concept/Strategy and Engineering Process Flow services in the same Nordic pharma market.
• CAI (Commissioning Agents, Inc.): Pharma and life sciences engineering services firm specializing in CQV, engineering operations and process improvement for biotech, pharmaceutical and nutraceutical manufacturers; competes for many of the same 'extended engineering consulting' engagements Harper & Vedel targets.
• PM Group: Ireland-based international engineering, architecture and construction firm serving pharma, food, medtech and advanced manufacturing clients; offers concept design, project management and EPCm services that overlap with Harper & Vedel's concept/strategy and process flow management offerings.
• Nemaco Engineering: Smaller Danish engineering consultancy serving Nordic pharma and process industry clients; offers process design, commissioning and engineering support directly comparable to Harper & Vedel's biotech/pharma advisory practice from a similar Nordic base.

Broad incumbents

• McKinsey & Company (Pharma Operations): Global strategy consulting firm with a sizable pharma and biotech operations practice serving high-end advisory clients; overlaps indirectly with Harper & Vedel's Concept/Strategy Studies for large pharma CapEx decisions, but typically competes at the strategic/risk layer rather than downstream engineering execution.
• Exyte (formerly M+W Group): Global high-tech facility design, engineering and construction firm with deep pharma and biotech expertise; competes with Harper & Vedel for early-stage advisory and process flow management, although typically delivers integrated turnkey projects rather than purely advisory engagements.
• Worley (formerly Jacobs Engineering / ECR): Large global engineering and professional services firm with a significant life sciences practice serving pharma, biotech and chemicals clients; offers strategy consulting, conceptual studies and full EPCm services, competing for upstream advisory work in the same client base as Harper & Vedel.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key highlights7 records

Customer concentration

• LinkedInlinkedin.com/company/harper-&-vedel

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Harper og Vedel IS